Related Experiment Video
Updated: Mar 22, 2026
12:03
Purification of Biotinylated Cell Surface Proteins from Rhipicephalus microplus Epithelial Gut Cells
Published on: July 23, 2017
10.0K
Host Immunization with Recombinant Proteins to Screen Antigens for Tick Control
Remil Linggatong Galay1, Takeshi Miyata2, Rika Umemiya-Shirafuji3
1Laboratory of Infectious Diseases, Joint Faculty of Veterinary Medicine, Kagoshima University, 1-21-24 Korimoto, Kagoshima, 890-0065, Japan.
Methods in Molecular Biology (Clifton, N.J.)
|April 15, 2016
Summary
Developing effective anti-tick vaccines is crucial for livestock health. This study outlines laboratory methods for evaluating a new vaccine candidate, assessing its potential to control tick infestations and pathogen transmission.
Area of Science:
- Veterinary Entomology
- Parasitology
- Vaccine Development
Background:
- Ticks transmit pathogens, impacting livestock and public health.
- Chemical acaricides face challenges like resistance and environmental contamination.
- Vaccination presents a sustainable alternative for tick control.
Purpose of the Study:
- To describe laboratory procedures for evaluating a novel anti-tick vaccine candidate.
- To assess the efficacy of a recombinant protein-based vaccine against tick infestation.
- To establish a framework for future anti-tick vaccine development.
Main Methods:
- Preparation of recombinant vaccine candidate proteins.
- Immunization of rabbit hosts and monitoring of antibody titers.
- Tick infestation challenges and assessment of vaccine effects on tick parameters.
Main Results:
- Detailed procedures for laboratory-level vaccine evaluation are presented.
- The study establishes a methodology for assessing anti-tick vaccine efficacy.
- This work contributes to the development of novel tick control strategies.
Conclusions:
- Laboratory evaluation of vaccine candidates is essential for developing effective anti-tick strategies.
- The described methods provide a foundation for assessing new vaccine antigens.
- Further research is needed to develop broad-spectrum anti-tick vaccines.
